- Exchange: Frankfurt
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Catalyst Pharmaceutical Partners Inc
+ Add to WatchlistCN2:GR
0.620 EUR 0.007 1.14%As of 10:35:58 ET on 05/20/2013.
Snapshot for Catalyst Pharmaceutical Partners Inc (CN2)
| Open: | 0.630 | Day's Range: | 0.611 - 0.655 | Volume: | 1,330 |
|---|---|---|---|---|---|
| Previous Close: | 0.613 | 52wk Range: | 0.271 - 1.552 | 1-Yr Rtn: | -7.05% |
Key Statistics for CN2
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(12/2013) | - |
| Relative P/E vs. DAX | - |
| Earnings Per Share (USD) (ttm) | - |
| Est. EPS (USD) (12/2013) | -0.2500 |
| Est. PEG Ratio | - |
| Market Cap (M EUR) | 0.00 |
| Shares Outstanding (M) | 0.00 |
| 30 Day Average Volume | 1,813 |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 08/15/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for CN2
No data available
Company Profile & Key Executives for CN2
Catalyst Pharmaceutical Partners, Inc. is a pharmaceutical company focused on the development and commercialization of prescription drugs for the treatment of addiction. The Company develops drugs for addictions such as methamphetamine, nicotine, prescription pain medications, alcohol, and marijuana, as well as treatments for related addictive disorders, such as obesity and gambling.
| Patrick J McEnanyChairman/President/CEO | Steven R MillerChief Operating Officer |
| Alicia GrandeVP/CFO/Treasurer | Charles W GorodetzkyChief Medical Officer |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
CN2 News
-
Industry News
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page